| Net Cash Provided by (Used in) Operating Activities |
$7,426,000 |
USD |
-292% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$15,600,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$16,630,000 |
USD |
-244% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
8,639,316 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$8,456,000 |
USD |
-160% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$29,304,000 |
USD |
-28% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,504,000 |
USD |
-2.6% |
Q1 2025 |
Q1 2025 |
| Depreciation |
$11,851,000 |
USD |
1.6% |
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$1,291,000 |
USD |
74% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$262,050,000 |
USD |
0.25% |
Q4 2025 |
FY 2025 |
| Current Federal Tax Expense (Benefit) |
$5,773,000 |
USD |
199% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$2,901,000 |
USD |
-8.9% |
Q1 2025 |
Q1 2025 |